NRBO Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | Woodworth Marshall H | officer: Chief Financial Officer | 33,496 | A-Award | A | 33,496 | 0.00 | 0.00 |
| 2023-12-01 | Tursi James Patrick | director | 32,157 | A-Award | A | 7,157 | 0.00 | 0.00 |
| 2023-12-01 | Tursi James Patrick | director | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2023-11-01 | Tursi James Patrick | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-10-27 | Woodworth Marshall H | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-08-11 | Kim Hyung Heon | director, officer: CEO & President | 625,064 | A-Award | A | 625,064 | 0.00 | 0.00 |
| 2023-07-27 | KOVEN ANDREW I | director | 100,000 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2023-07-27 | KOVEN ANDREW I | director | 87,500 | A-Award | A | 87,500 | 0.00 | 0.00 |
| 2023-07-27 | Salsbury Michael | director | 100,000 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2023-07-27 | Salsbury Michael | director | 87,500 | A-Award | A | 87,500 | 0.00 | 0.00 |
| 2023-07-27 | STRICKLAND D GORDON | director | 100,000 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2023-07-27 | STRICKLAND D GORDON | director | 87,500 | A-Award | A | 87,500 | 0.00 | 0.00 |
| 2023-07-27 | GROVES JASON L | director | 100,000 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2023-07-27 | GROVES JASON L | director | 87,500 | A-Award | A | 87,500 | 0.00 | 0.00 |
| 2023-07-27 | Glickman Mark A | director | 37,500 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2023-07-27 | Glickman Mark A | director | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2023-07-27 | Kim Na Yeon | director, 10 percent owner: | 101,459 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2023-07-27 | Kim Na Yeon | director, 10 percent owner: | 88,959 | A-Award | A | 87,500 | 0.00 | 0.00 |
| 2022-07-26 | Kim Na Yeon | director, 10 percent owner: | 4,671 | J-Other | A | 4,671 | 0.00 | 0.00 |
| 2023-05-11 | Glickman Mark A | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-01-12 | Hooker Joseph | None | 0 | None | None | 0.00 | ||
| 2023-01-12 | Hooker Joseph | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-11-16 | GOLDMAN SACHS GROUP INC | director | 1,220,502 | I | 0 | 0.00 | 0.00 | |
| 2022-07-26 | E&Healthcare Investment Fund II | director: | 2,890,533 | J-Other | D | 1,445,267 | 0.00 | 0.00 |
| 2022-07-26 | Kim Na Yeon | director: | 2,890,533 | J-Other | D | 1,445,267 | 0.00 | 0.00 |
| 2022-06-09 | Kim Na Yeon | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-09 | GROVES JASON L | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-09 | GROVES JASON L | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | Kim Hyung Heon | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-09 | Kang Richard | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-09 | STRICKLAND D GORDON | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-09 | Salsbury Michael | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-09 | Salsbury Michael | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | KOVEN ANDREW I | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-09 | KOVEN ANDREW I | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-01-27 | STRICKLAND D GORDON | director | 40,000 | A-Award | A | 40,000 | 1.02 | 40,800.00 |
| 2022-01-27 | STRICKLAND D GORDON | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-11-03 | Price Ben Gil | officer: CEO and President | 616,666 | A-Award | A | 616,666 | 2.04 | 1,257,999.00 |
| 2021-11-03 | Price Ben Gil | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2021-09-02 | KOVEN ANDREW I | director | 60,000 | A-Award | A | 60,000 | 4.52 | 271,200.00 |
| 2021-07-09 | Kim Hyung Heon | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-07-09 | KOVEN ANDREW I | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2020-12-31 | Bakshi Akash | director, officer: SVP and COO | 884,072 | A-Award | A | 855,059 | 0.00 | 0.00 |
| 2020-12-31 | Bakshi Akash | director, officer: SVP and COO | 29,013 | A-Award | A | 29,013 | 0.00 | 0.00 |
| 2020-12-31 | Bakshi Akash | director, officer: SVP and COO | 0 | 0 | 0.00 | 0.00 | ||
| 2020-09-01 | Swirsky Douglas J | director | 60,000 | A-Award | A | 60,000 | 6.04 | 362,400.00 |
| 2020-09-01 | Swirsky Douglas J | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | JK BioPharma Solutions, Inc | 10 percent owner | 1,817,842 | D | 0 | 0.00 | 0.00 | |
| 2019-12-30 | JK BioPharma Solutions, Inc | 10 percent owner | 800,170 | D | 0 | 0.00 | 0.00 | |
| 2020-01-13 | Salsbury Michael | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Oh Jeong Gyun | director, 10 percent owner: | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Kim Na Yeon | director, 10 percent owner: | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Jeong Tae Heum | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Gullans Steven R. Ph.D. | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | GROVES JASON L | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2019-12-30 | E&Investment, Inc. | 10 percent owner | 4,335,800 | I | 0 | 0.00 | 0.00 | |
| 2019-12-30 | E&Investment, Inc. | 10 percent owner | 1,864,799 | I | 0 | 0.00 | 0.00 | |
| 2019-12-30 | E&Investment, Inc. | 10 percent owner | 1,121,190 | I | 0 | 0.00 | 0.00 | |
| 2019-12-30 | JK BioPharma Solutions, Inc | 10 percent owner | 1,817,842 | D | 0 | 0.00 | 0.00 | |
| 2019-12-30 | JK BioPharma Solutions, Inc | 10 percent owner | 800,170 | D | 0 | 0.00 | 0.00 | |
| 2019-12-30 | E&Investment, Inc. | 10 percent owner | 4,335,800 | I | 0 | 0.00 | 0.00 | |
| 2019-12-30 | E&Investment, Inc. | 10 percent owner | 1,864,799 | I | 0 | 0.00 | 0.00 | |
| 2019-12-30 | E&Investment, Inc. | 10 percent owner | 1,121,190 | I | 0 | 0.00 | 0.00 | |
| 2019-12-30 | DONG-A ST CO., LTD | 10 percent owner | 2,880,612 | D | 0 | 0.00 | 0.00 | |
| 2019-12-30 | Versavel Mark | officer: Chief Medical Officer | 297,206 | A-Award | A | 297,206 | 0.63 | 187,240.00 |
| 2019-12-30 | Versavel Mark | officer: Chief Medical Officer | 45,724 | A-Award | A | 45,724 | 0.63 | 28,806.00 |
| 2019-12-30 | Oh Jeong Gyun | director, 10 percent owner: | 1,817,842 | A-Award | A | 1,817,842 | 0.00 | 0.00 |
| 2019-12-30 | Oh Jeong Gyun | director, 10 percent owner: | 240,051 | A-Award | A | 240,051 | 0.00 | 0.00 |
| 2019-12-30 | Kim Na Yeon | director, 10 percent owner: | 4,335,800 | A-Award | A | 4,335,800 | 0.00 | 0.00 |
| 2019-12-30 | Kim Na Yeon | director, 10 percent owner: | 1,864,799 | A-Award | A | 1,864,799 | 0.00 | 0.00 |
| 2019-12-30 | Kim Na Yeon | director, 10 percent owner: | 1,121,190 | A-Award | A | 1,121,190 | 0.00 | 0.00 |
| 2019-12-30 | Oh Jeong Gyun | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | Kim Na Yeon | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | Kang Jeong Gu | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | Shannon Nicola | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | Versavel Mark | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | Salsbury Michael | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | GROVES JASON L | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-12-30 | Jeong Tae Heum | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2019-07-24 | SASSINE ANDY | director | 151,264 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2019-07-24 | LICHTINGER PEDRO | director | 74,833 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2019-07-24 | KOUSKY KENNETH W | director | 26,935 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2019-07-24 | Reno Seth | officer: Chief Commercial Officer | 118,286 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2019-07-24 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 1,348,914 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2019-07-24 | Gullans Steven R. Ph.D. | director, officer: President & CEO | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2018-05-22 | Gullans Steven R. Ph.D. | director, officer: President & CEO | 50,000 | A-Award | A | 50,000 | 5.56 | 278,000.00 |
| 2018-05-01 | Gullans Steven R. Ph.D. | director, officer: President & CEO | 150,000 | A-Award | A | 150,000 | 5.56 | 834,000.00 |
| 2018-02-08 | Reno Seth | officer: Chief Commercial Officer | 18,286 | P-Purchase | A | 14,286 | 7.00 | 100,002.00 |
| 2018-02-08 | Gullans Steven R. Ph.D. | director, officer: Interim President & CEO | 930,252 | P-Purchase | A | 71,429 | 7.00 | 500,003.00 |
| 2018-01-29 | SASSINE ANDY | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-29 | LICHTINGER PEDRO | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-29 | KOUSKY KENNETH W | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-29 | Hawryluk P. Kent | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-28 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scien Officer & Chair | 48,000 | A-Award | A | 48,000 | 10.10 | 484,800.00 |
| 2018-01-28 | Golden Lee Scott | officer: Chief Medical Officer | 148,000 | A-Award | A | 148,000 | 10.10 | 1,494,800.00 |
| 2018-01-28 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 48,000 | A-Award | A | 48,000 | 10.10 | 484,800.00 |
| 2018-01-28 | Reno Seth | officer: Chief Commercial Officer | 48,000 | A-Award | A | 48,000 | 10.10 | 484,800.00 |
| 2018-01-29 | Gullans Steven R. Ph.D. | director, officer: Interim President & CEO | 60,000 | A-Award | A | 60,000 | 10.44 | 626,400.00 |
| 2017-08-14 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 14,134 | M-Exempt | A | 3,207 | 3.59 | 11,513.00 |
| 2017-08-14 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 0 | M-Exempt | D | 3,207 | 3.59 | 11,513.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
